drugset / Trial / NCT00038207
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if treatment with the drug liposomal vincristine can shrink or slow the growth of the patient's cancer. The safety of this drug will also be studied.
Timeline
- Start
- 2000-06
- Primary completion
- 2004-09
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liposomal Vincristine | Unknown | 2 mg/m2 | Intravenous |